Immunogenicity and safety of an inactivated quadrivalent influenza vaccine co-administered with a 23-valent pneumococcal polysaccharide vaccine versus separate administration,in adults ≥50 years of age: Results from a phase III,randomized, non-inferiority trial |
| |
摘 要: |
|
收稿时间: | 2017-07-19 |
本文献已被 ScienceDirect 等数据库收录! |
|